We report the clinical features of, and the molecular study performed on, a Spanish family with essential tremor (ET), late onset epilepsy and autosomal dominant hypokalemic periodic paralysis (hypoPP). The presence of hypoPP in this kindred suggested an ion channel as a candidate gene for ET. Our study identified an Arg528His CACNL1A3 mutation in patients with hypoPP, and excluded this mutation as the cause of tremor or epilepsy in this kindred.
INTRODUCTION
Essential tremor (ET) is the most common movement disorder and one of the most frequent neurological diseases 1, 2 . The importance of genetic factors in ET pathogenesis is unanimously endorsed, due to its frequent familial presentation and to the absence of known environmental factors that could explain its pathogenesis. To date, two loci have been identified by linkage analysis in familial ET. The 3q13 locus was reported in Iceland pedigrees 3 and the 2p22-p25 locus in one additional family 4 . These kindreds developed an autosomal dominant form of ET, similar to the sporadic form. These results have not been replicated in other pedigrees. Thus, despite the high prevalence of this disease, available molecular genetic information is scarce.
The factors that challenge the detection of genes underlying ET include: incomplete and sometimes low penetrance; the presence of atypical clinical features; the existence of individuals in the pedigree affected by sporadic, nongenetic causes of ET or phenocopies; and the wide range of age of onset within families 5 .
These factors complicate the correct assignment of affectation status to a given subject. Among different kindreds, the existence of genetic heterogeneity, with different genes leading to the same or similar phenotype, may obscure the detection of genetic linkage when multiple families are summed in linkage studies.
These facts reinforce the use of a different methodology, such as candidate gene mutation analysis, to evaluate ET pedigrees. In this approach, a particular gene is hypothesized to be the locus for the disease, as suggested for example by the cosegregation of the disorder under study with diseases of known genetic origin. The subsequent molecular genetic study will reveal if mutations in the candidate gene are present in patients but not in normal controls 6 . In the present work, genes related to ion channel diseases could be considered as candidates for ET, given the good response some ET patients have to calcium channel blockers 7, 8 , or carbonic anhydrase inhibitors 9, 10 .
In this paper we report a Spanish family with associated essential tremor, late onset complex partial seizures and hypokalemic periodic paralysis (hypoPP). These phenotypes could be explained by a mutation in a single gene, e.g. a channelopathy. Familial hypoPP is due in most cases to mutations in the CACNL1A3 gene, which encodes the α1 subunit of the dihydropyridine receptor 11, 12 . Also, epileptic seizures have been seen in other channelopathies [13] [14] [15] [16] , and there are forms of malignant hyperthermia, a disorder allelic to familial hypoPP 17 , linked to a locus in the same chromosomal region as familial ET 18 . We report the clinical features of this family and the molecular study performed, to see if mutations in CACNL1A3 were responsible for part or all of the neurological phenotypes described. 
PATIENTS AND METHODS

Pedigree overview
The following data are from the kindred pedigree as shown in Fig. 1 . All individuals were directly evaluated by at least one of us. Evaluation consisted of a neurological history and physical examination to ascertain affection status. We performed laboratory studies including plasma glucose, creatinine, hepatic function, erythrocyte sedimentation rate, creatine kinase and thyroid status. The diagnosis of ET was based on the presence of postural and kinetic tremor unilaterally or bilaterally, anytime during the study period and on the absence of any secondary causes. HypoPP was diagnosed when there was a typical history of transient paralytic attacks. Hypokalemia during attacks was observed but not considered a prerequisite. Age at onset of ET seizures or hypoPP was defined as the age when an individual first complained of these neurological symptoms. ET patients were videotaped according to a standard protocol.
Molecular genetic study
Blood samples were collected after informed consent. Total genomic DNA was isolated from blood leukocytes by hypotonic lysis, followed by standard phenol-chloroform extraction and ethanol precipitation. Arg528His and Arg1239His mutations in the CACNL1A3 gene, reported to exist in patients with familial hypoPP, were studied by restriction enzyme analysis, as previously described 11, 12, 19 . This procedure is feasible in both cases because the Arg528His mutation (CGC→CAC) causes the loss of a BbvI site, while the Arg1239His mutation (CGT→CAT) creates a new NlaIII restriction site. The procedure involved PCR amplification, overnight enzyme digestion, 16% polyacrylamide gel separation, and ethidium bromide staining. Table 1 shows PCR primer pairs, annealing temperatures and product lengths, along with restriction enzymes and fragment lengths after digestion, for normal and mutated DNA.
RESULTS AND CASE REPORTS Pedigree overview
The kindred included four members in two consecutive generations. The pedigree diagram in Fig. 1 shows its pattern of inheritance and clinical manifestations, along with restriction enzyme analysis results. Clinical data are summarized in Table 2 . Detailed case histories are presented below. Two individuals in the first generation had late onset seizures and ET, one with hypoPP. In the second generation one individual had hypoPP, while his sister was not affected, and neither have developed seizures or tremor so far. The average age at onset was 15 years old for hypoPP, 57 years old for seizures and 68 years old for ET. The ET phenotype was identical to that seen in sporadic cases, with asymmetric involvement initially, mild cogwheel rigidity and neither akinesia nor postural instability. Rate of progression was slow. Seizures were complex partial or generalized. They were controlled with medication (phenytoin or phenobarbitone) and tremor partially responded to phenobarbitone. Dementia, pyramidal, cerebellar or autonomic disturbances were not found. Laboratory investigations were normal in all subjects. In spite of the small size of this pedigree, hypoPP seemed to be transmitted with an autosomal dominant pattern. It was not possible to assign a mode of inheritance for ET and seizures as they were present only in the first generation. However, in view of a positive history in one of the parents (not included, as deceased), and to the absence of known consanguinity, ET was also assumed to be an autosomal dominant.
Case reports
Case I-1.
This 80-year-old man presented attacks of periodic paralysis caused by stress or exercise since his teens, once every two to six months, until his fifties. Since then he has had no more attacks. When 51 years old he began to have episodes of impaired awareness and motor automatism that were treated with phenobarbitone and phenytoin with good response. The medication was withdrawn 5 years later and the ictal episodes recurred. At 71 years old he was first evaluated by us, complaining of tremor in both upper limbs that interfered with writing and eating. An EEG showed focal left sharp wave discharges and a contrast-enhanced cranial CT was normal. Tremor progressed slowly, and, at the time of this report, 9 years later, it impaired writing and daily activities. Propranolol ameliorated the tremor but was discontinued because of associated adverse effects. Nimodipine did not improve his tremor.
Case I-2.
This 84-year-old man had a history of complex partial and generalized seizures, since he was 64. An EEG showed bilateral temporal slow wave discharges, and a cranial CT was normal. Since he was 74, he had mild tremor in his left upper limb. Ten years later, seizures were under good control with phenobarbitone, and tremor did not impair his usual daily activities. ET involved mainly the left forearm, in certain postures at rest, but could also be seen while maintaining posture and in the finger-nose manoeuvre. At 79 years he had two episodes of transient ataxia and diplopia, evaluated elsewhere as vertebrobasilar ischemic attacks.
Another cranial CT at that time was normal. He did not have episodes of periodic paralysis.
Case II-1.
This 45-year-old woman had neither periodic paralysis nor epileptic seizures or tremor.
Case II-2.
This 42-year-old man had periodic episodes of generalized paralysis since 15 years of age, caused by stress or exercise. Two of the episodes were observed in our hospital and mild hypokalemia was recorded. There was no evidence of epilepsy or tremor, at the time of assessment.
Mutation analysis
NlaIII enzyme analysis showed normal results in all the individuals, excluding an Arg1239His mutation. On the other hand, after digestion with BbvI, cases I-1 and II-2 showed a 77 bp band along with the normal 33 and 44 bp bands, concordant to a heterozygote state for the Arg528His mutation. Cases I-2 and II-1, did not have this mutation. These results confirmed that familial hypoPP in this kindred was inherited in an autosomal dominant fashion, due to this CACNL1A3 gene mutation, with complete penetrance. The Arg528His mutation did not segregate with the ET trait (Fig. 1) .
DISCUSSION
Familial hypoPP is a disorder of muscle excitability characterized by transient attacks of hypotonic paralysis with variable severity and duration, and associated mild hypokalemia, that occur at intervals of days to years 20, 21 . The main provocative factors are rest after exercise and carbohydrate-rich meals.
The most frequent age of onset is within the second decade of life, and it usually remits at older ages. It is an autosomal dominant disease with incomplete penetrance 19 . Late in the course of the dis-ease these patients may develop a vacuolar myopathy, not related to the frequency or intensity of episodes. It is a voltage-gated muscle calcium channel disorder. Initial genetic studies linked this disease to a locus in chromosome 1q 22 ; later, it was discovered to correspond to mutations in the CACNL1A3 gene which encodes the α1 subunit of the skeletal muscle L-type calcium channel, named the dyhidropyridine receptor 11 . Three point mutations have been identified in this gene, to date: Arg528His, Arg1239His and Arg1239Gly. The first one is the most usual, while the last one is very uncommon 11, 12 . Nevertheless these mutations do not explain all familial hypoPP cases.
There are no reports of other neurological disorders in familial hypoPP. However, the family we report presented hypoPP, along with late-onset seizures and ET, only manifest in the first generation studied to date. The late-onset age of tremor and seizures in this kindred could explain the absence of these manifestations in the second generation individuals. Also, as familial hypoPP may have an incomplete penetrance, case I-2 could be an asymptomatic carrier of this trait. Moreover, as referred above, both ET and hypoPP seemed to be transmitted with an autosomal dominant pattern. All these facts suggest that a mutation in a single gene with variable penetrance could be the cause of these phenotypes.
Both clinical and genetic factors point to an ion channel disorder in the family presented: on clinical grounds, this interpretation agrees with several reports of a positive response in ET to calcium-receptor antagonists, which bind to the dyhidropyridine receptor, an L-type voltage-gated receptor 7, 8 . Genetic justification for our hypothesis includes evidence that relate epilepsy or tremor to channelopathies. Specific epileptic syndromes are associated with mutations in the gene for the β1 subunit of voltage-gated sodium channel SCN1B 13 , and in the potassium channel genes KCNQ2 and KCNQ3 14, 15 . In addition, a disturbance in the ATP-sensitive potassium channel system has been found in patients with familial hypoPP 20 . Also, individuals with mutations in the human voltage-gated potassium channel Kv1.1, responsible for episodic ataxia type 1, sometimes have generalized or secondarily generalized seizures, during the course of the disease 16 , and a mouse knockout for Kv1.1 has a lethal epilepsy phenotype 23 . Moreover, CACNA1A gene mutations, responsible for episodic ataxia type 2 and migraine in humans, cause seizures in mice 24 . Tremor mimicking essential tremor can be seen in both episodic ataxia type 1 and type 2 16, 25 . Finally, one of the loci associated with familial ET is in the same chromosomal region as a form of malignant hyperthermia (3q13) 3, 17 . This disease is usually caused by alterations in the ryanodine receptor, but there is a form, allelic with hypoPP 18 , in which an alteration in the dyhidropyridine receptor causes an abnormal interaction with the ryanodine receptor in the electrical-mechanical coupling of muscle contraction.
Taking all above considerations together, genes that could link ET and/or epileptic seizures to familial hypoPP in the kindred presented include those coding the L-type calcium channel. Among these, the CACNL1A3 gene is a good candidate, since it is responsible for most cases of familial hypoPP but, as stated above, mutations have not been linked so far to systemic diseases. We therefore performed a molecular analysis of CACNL1A3 mutations that could account for hypoPP in this family. At the same time, the molecular analysis would help to confirm or exclude the hypothesis of a single monogenic disease responsible for the phenotypes in this kindred.
The molecular analysis of CACNL1A3 gene mutations performed by us showed that case I-2, with ET and late onset seizures, did not have the Arg528His mutation that segregated with the hypoPP trait. The coexistence of seizures and ET of similar characteristics and age of onset in cases I-1 and I-2 makes it very unlikely that there is a phenocopy in case I-2. This family thus presented hypoPP caused by an Arg528His mutation in the CACNL1A3 gene in two individuals, and unlinked familial ET and late onset seizures in others. Moreover, calcium channel antagonists did not relieve the tremor. In conclusion, these results do not support an L-type calcium channel as a candidate gene for ET in the family presented.
